Get startedLog in
    Picture of SciClone Pharmaceuticals (Holdings) logo

    6600 — SciClone Pharmaceuticals (Holdings) News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: SciClone Says Study For COVID-19 Inactivated Vaccine With Thymalfasin Initiated

    Picture of SciClone Pharmaceuticals (Holdings) logoSciClone Pharmaceuticals (Holdings)
    26/04/2021 01:43
    April 26 (Reuters) - SciClone Pharmaceuticals (Holdings) Ltd
 6600.HK :
    * CLINICAL STUDY FOR COVID-19 INACTIVATED VACCINE COMBINED
WITH
THYMALFASIN INITIATED ON APRIL 25

Source text for Eikon:  ID:nHKS8hMD5T 
Further company coverage:  6600.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on SciClone Pharmaceuticals (Holdings)

    See all news